Zoledronic Acid For Injection Market

Zoledronic acid is a third-generation bisphosphonate compound developed by Novartis for the treatment of osteoporosis, osteitis deformans (Paget's disease of bone), bone metastases, multiple myeloma and tumour-induced hypercalcaemia.

Zoledronic Acid For Injection Market contains market size and forecasts of Zoledronic Acid For Injection in global, including the following market information:

Global Zoledronic Acid For Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Zoledronic Acid For Injection Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Zoledronic Acid For Injection companies in 2021 (%)

The global Zoledronic Acid For Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Liquid Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Zoledronic Acid For Injection include Novartis, Teva Pharmaceutical, Pfizer, Hikma Pharmaceuticals, Gland Pharma, Apotex, Chia Tai Tianqing Pharmaceutical Group, Jiangsu Aosaikang Pharmaceutical and Jiangsu Hengrui Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Zoledronic Acid For Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Zoledronic Acid For Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Zoledronic Acid For Injection Market Segment Percentages, by Type, 2021 (%)

Liquid

Solid

Global Zoledronic Acid For Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Zoledronic Acid For Injection Market Segment Percentages, by Application, 2021 (%)

Hospital

Clinic

Other

Global Zoledronic Acid For Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Zoledronic Acid For Injection Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Zoledronic Acid For Injection revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Zoledronic Acid For Injection revenues share in global market, 2021 (%)

Key companies Zoledronic Acid For Injection sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Zoledronic Acid For Injection sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Novartis

Teva Pharmaceutical

Pfizer

Hikma Pharmaceuticals

Gland Pharma

Apotex

Chia Tai Tianqing Pharmaceutical Group

Jiangsu Aosaikang Pharmaceutical

Jiangsu Hengrui Pharmaceuticals

Lunan Pharmaceutical Group

Xidian Pharmaceutical

Nanjing Pharmaceutical Factory

Shenzhen Neptunus Pharmaceutical

Sichuan Hairong Pharmaceutical

Qilu pharmaceutical

China National Medicines Guorui Pharmaceutical